Published in Psychopharmacology (Berl) on August 29, 2008
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep (2012) 1.24
Targeting glutamate synapses in schizophrenia. Trends Mol Med (2011) 1.06
Glutamatergic targets for enhancing extinction learning in drug addiction. Curr Neuropharmacol (2010) 0.95
Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1. Neuroscience (2009) 0.86
The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome. Am J Med Genet A (2015) 0.83
The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci (2016) 0.82
Inhibiting glycine transporter-1 facilitates cocaine-cue extinction and attenuates reacquisition of cocaine-seeking behavior. Drug Alcohol Depend (2011) 0.82
Glycine transporter-1 inhibition preceding extinction training inhibits reacquisition of cocaine seeking. Neuropsychopharmacology (2012) 0.81
Glycine transporter 1 is a target for the treatment of epilepsy. Neuropharmacology (2015) 0.80
Working memory and the homeostatic control of brain adenosine by adenosine kinase. Neuroscience (2012) 0.80
1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology (Berl) (2014) 0.79
Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia. Eur Neuropsychopharmacol (2012) 0.78
Intact working memory in the absence of forebrain neuronal glycine transporter 1. Behav Brain Res (2012) 0.76
SSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine. Psychopharmacology (Berl) (2013) 0.75
Deletion of forebrain glycine transporter 1 enhances conditioned freezing to a reliable, but not an ambiguous, cue for threat in a conditioned freezing paradigm. Behav Brain Res (2014) 0.75
Genetic enhancement of learning and memory in mice. Nature (1999) 8.06
Professor's little helper. Nature (2007) 5.61
Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry (1995) 5.59
N-methyl-D-aspartic acid receptor structure and function. Physiol Rev (1994) 3.08
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology (1975) 2.76
Brain mechanisms of proactive interference in working memory. Neuroscience (2005) 2.60
Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res (2005) 2.41
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry (1999) 2.36
Glycine binding primes NMDA receptor internalization. Nature (2003) 2.30
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev (1998) 2.28
Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci (1989) 2.17
Nonvesicular release of neurotransmitter. Neuron (1993) 2.17
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. Arch Gen Psychiatry (2005) 2.08
Memories of NMDA receptors and LTP. Trends Neurosci (1995) 1.76
Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A (1998) 1.71
Mazes, maps, and memory. Am Psychol (1979) 1.68
Glycine receptors: recent insights into their structural organization and functional diversity. J Neurochem (2006) 1.61
D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacology (2007) 1.60
Ligands for glutamate receptors: design and therapeutic prospects. J Med Chem (2000) 1.58
Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons. Behav Neurosci (2007) 1.56
Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory. Behav Neurosci (2007) 1.48
NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory. J Neurosci (2008) 1.47
The glycine receptor. Pharmacol Ther (1997) 1.44
Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. J Neurophysiol (2003) 1.38
Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb Cortex (2005) 1.37
Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J Neurophysiol (1998) 1.35
The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res (1986) 1.34
Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses? Trends Pharmacol Sci (2002) 1.31
D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav (1989) 1.29
NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol (2004) 1.29
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology (2005) 1.24
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23
Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry (2004) 1.22
The drugs don't work-or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory. Psychopharmacology (Berl) (2006) 1.19
Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biol Psychiatry (1993) 1.19
Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol (2004) 1.14
The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats. Alcohol Alcohol (2006) 1.14
Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia (2006) 1.10
Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry (1996) 1.09
Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion. Trends Pharmacol Sci (2005) 1.05
IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans. Biol Psychiatry (2000) 1.03
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatry (2004) 1.02
Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment. Psychopharmacology (Berl) (2007) 0.97
Dorsal hippocampal N-methyl-D-aspartate receptors underlie spatial working memory performance during non-matching to place testing on the T-maze. Behav Brain Res (2007) 0.95
Pharmacological manipulation of human working memory. Psychopharmacology (Berl) (2004) 0.94
The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing. Brain Res (2006) 0.93
Dopaminergic enhancement of cognitive function. Curr Pharm Des (2006) 0.93
N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review. Curr Drug Targets CNS Neurol Disord (2002) 0.90
Removal of the hippocampus and transection of the fornix produce comparable deficits on delayed non-matching to position by rats. Behav Brain Res (1992) 0.89
Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol (2001) 0.88
N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade. Int J Neuropsychopharmacol (2000) 0.88
The effects of hippocampal formation ablation or fimbria-fornix section on performance of a nonspatial radial arm maze task by rats. J Neurosci (1994) 0.88
Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists. Psychopharmacology (Berl) (1995) 0.87
Glutamate-based therapeutic approaches: inhibitors of glycine transport. Curr Opin Pharmacol (2005) 0.86
The scaffolding protein PSD-95 interacts with the glycine transporter GLYT1 and impairs its internalization. J Neurochem (2005) 0.85
Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. Neuroreport (1990) 0.85
NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice. Psychopharmacology (Berl) (2007) 0.82
Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze. J Psychopharmacol (1999) 0.81
Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls. Psychopharmacology (Berl) (2007) 0.80
The hippocampus, time and working memory. Behav Brain Res (1983) 0.79
D-Cycloserine enhances conditioned taste aversion learning in rats. Pharmacol Biochem Behav (2007) 0.79
Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Brain Res (1989) 0.77
Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.76
The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls. Hum Psychopharmacol (2008) 0.75
High dose glycine nutrition affects glial cell morphology in rat hippocampus and cerebellum. Int J Neuropsychopharmacol (1999) 0.75
A comparison between the effects of medial septal lesions and entorhinal cortex lesions on performance of nonspatial working memory tasks and reversal learning. Behav Brain Res (1998) 0.75
Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (2013) 3.83
The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci (2006) 3.03
Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol (2004) 2.38
Abnormal differentiation of newborn granule cells in age-related working memory impairments. Neurobiol Aging (2008) 2.38
Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun (2007) 1.86
Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev (2003) 1.78
In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev (2009) 1.74
Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol (2009) 1.73
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev (2005) 1.70
Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research. Neurosci Biobehav Rev (2005) 1.70
Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat. Behav Brain Res (2004) 1.65
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons. Behav Neurosci (2007) 1.56
Double dissociation of the effects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour and salience learning in rats. Eur J Neurosci (2005) 1.54
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull (2008) 1.49
Hippocampal modulation of sensorimotor processes. Prog Neurobiol (2003) 1.47
Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol (2004) 1.45
The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist (2007) 1.42
Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci (2004) 1.42
Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J Neurochem (2004) 1.38
Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus (2003) 1.35
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun (2005) 1.27
A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci (2010) 1.24
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol (2008) 1.21
GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur J Neurosci (2004) 1.21
Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology (2007) 1.18
Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions. Physiol Behav (2002) 1.17
Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology (2007) 1.13
Performance of the marmoset monkey on computerized tasks of attention and working memory. Brain Res Cogn Brain Res (2004) 1.12
Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology (2010) 1.12
Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav Brain Res (2002) 1.11
Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One (2009) 1.10
The impact of voluntary exercise on mental health in rodents: a neuroplasticity perspective. Behav Brain Res (2008) 1.09
The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development. Dev Psychobiol (2006) 1.08
DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther (2007) 1.08
Early deprivation and behavioral and physiological responses to social separation/novelty in the marmoset. Pharmacol Biochem Behav (2002) 1.07
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull (2008) 1.07
ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis (2003) 1.06
Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry (2002) 1.06
Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res (2008) 1.05
Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behav Brain Res (2006) 1.05
Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP. Eur J Neurosci (2010) 1.05
Early life stress: long-term physiological impact in rodents and primates. News Physiol Sci (2002) 1.03
Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res (2006) 1.03
Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging (2007) 1.02
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem (2011) 1.01
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) (2009) 1.01
To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology (2011) 1.01
Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci (2007) 1.00
A differential involvement of the shell and core subterritories of the nucleus accumbens of rats in memory processes. Behav Neurosci (2003) 1.00
On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci (2008) 1.00
Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci U S A (2003) 1.00
The postweaning social isolation in C57BL/6 mice: preferential vulnerability in the male sex. Psychopharmacology (Berl) (2008) 1.00
Effect of a single maternal separation at different pup ages on the corticosterone stress response in adult and aged rats. Pharmacol Biochem Behav (2002) 0.99
Deprivation of parenting disrupts development of homeostatic and reward systems in marmoset monkey offspring. Biol Psychiatry (2004) 0.99
Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy? Curr Pharm Des (2015) 0.99
Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. Neuropsychopharmacology (2008) 0.99
Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition. Biochem Pharmacol (2011) 0.98
Effects of prenatal dexamethasone treatment on postnatal physical, endocrine, and social development in the common marmoset monkey. Endocrinology (2007) 0.98
Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. J Neurosci (2012) 0.98
Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology (Berl) (2009) 0.97
The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacology (2004) 0.97
Repeated parental deprivation in the infant common marmoset (Callithrix jacchus, primates) and analysis of its effects on early development. Biol Psychiatry (2002) 0.95
The role of voluntary exercise in enriched rearing: a behavioral analysis. Behav Neurosci (2006) 0.95
Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res (2007) 0.94
Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity. Neuropsychopharmacology (2004) 0.93
Early deprivation under specific conditions leads to reduced interest in reward in adulthood in Wistar rats. Behav Brain Res (2005) 0.93
Early deprivation leads to altered behavioural, autonomic and endocrine responses to environmental challenge in adult Fischer rats. Eur J Neurosci (2006) 0.93
Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cereb Cortex (2003) 0.93
Early deprivation leads to long-term reductions in motivation for reward and 5-HT1A binding and both effects are reversed by fluoxetine. Neuropharmacology (2008) 0.93
Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology (2008) 0.93
Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system. Mov Disord (2003) 0.93